Nebenwirkungen · Stivarga
Stivarga 40 mg film-coated tablets. · Abschnitt 4.8 · PDF-Seite 10–11
HOS-127111 · Präparat HOS-096369
10 System Organ Class Very common Common Uncommon Rare Not known (MedDRA) Metabolism Decreased Hypo- and nutrition appetite and kalaemia disorders food intake Hypophos- phatemia Hypo- calcaemia Hypo- natraemia Hypomag- nesaemia Hyperuri- caemia Dehy- dration Nervous Headache Posterior Hyperammon system Tremor reversible aemic disorders Peripheral encephalo- encephalopat neuropathy pathy hy syndrome (PRES) Cardiac Myocardial disorders infarction Myocardial ischaemia Vascular Haemorrhage* Hypertensive Aneurysms disorders Hypertension crisis and artery dissections Respiratory, Dysphonia thoracic and mediastinal disorders Gastro- Diarrhoea Taste Gastro- intestinal Stomatitis disorders intestinal disorders Vomiting Dry mouth perforation* Nausea Gastro- Gastro- Constipation oesopha- intestinal geal reflux fistula Gastro- Pancreatitis enteritis Hepatobiliary Hyper- Severe liver disorders bilirubinaemia injury Increase in (including transaminases hepatic failure)*# Skin and Hand-foot Alopecia Nail disorder Stevens- subcutaneous skin Dry skin Erythema Johnson tissue reaction** Exfoliative multiforme syndrome disorders Rash rash Toxic epidermal necrolysis
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-24T12:26:00Z · SHA-256 188477d5802aa3c29bbcc6435c9e581d56ccf3178a537b51e23d7bce8cf4f8be · Passage 4602edec10552ceaeb5d6e51df08e87a919d23e611b293abcaba3e2267efb924 · Zeichen 3062–5973 im Abschnitt